Shaoqing Chen

Nanchang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Sequential PD-1 inhibitor after adjuvant radiotherapy for postoperative oral cancer: a propensity score matching retrospective cohort study.

Sequential PD-1 inhibitor after adjuvant radiotherapy for postoperative oral cancer: a propensity score matching retrospective cohort study.

Journal: Frontiers in oncology

Published: January 29, 2026

Izalontamab brengitecan, an EGFR and HER3 bispecific antibody-drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China.

Izalontamab brengitecan, an EGFR and HER3 bispecific antibody-drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China.

Journal: Lancet (London, England)

Published: September 08, 2025

Pan-cancer analysis identified DOK3 as a novel biomarker for predicting prognosis and immunotherapy effectiveness.

Pan-cancer analysis identified DOK3 as a novel biomarker for predicting prognosis and immunotherapy effectiveness.

Journal: Discover oncology

Published: June 18, 2025

Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309).

Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309).

Journal: Cancer cell

Published: August 25, 2022

Clinical Analysis of 50 Cases of Primary Pulmonary Lymphoma: A Retrospective Study and Literature Review.

Clinical Analysis of 50 Cases of Primary Pulmonary Lymphoma: A Retrospective Study and Literature Review.

Journal: Technology in cancer research & treatment

Published: March 07, 2022

Nomogram Predicting Cancer-Specific Death in Parotid Carcinoma: a Competing Risk Analysis.

Nomogram Predicting Cancer-Specific Death in Parotid Carcinoma: a Competing Risk Analysis.

Journal: Frontiers in oncology

Published: April 22, 2021

A Competing Risk Nomogram for Predicting Cancer-Specific Death of Patients With Maxillary Sinus Carcinoma.

A Competing Risk Nomogram for Predicting Cancer-Specific Death of Patients With Maxillary Sinus Carcinoma.

Journal: Frontiers in oncology

Published: April 22, 2021

The long non-coding RNA MACC1-AS1 promotes nasopharyngeal carcinoma cell stemness via suppressing miR-145-mediated inhibition on SMAD2/MACC1-AS1 axis.

The long non-coding RNA MACC1-AS1 promotes nasopharyngeal carcinoma cell stemness via suppressing miR-145-mediated inhibition on SMAD2/MACC1-AS1 axis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 16, 2019

Silencing of long noncoding RNA SRRM2-AS exerts suppressive effects on angiogenesis in nasopharyngeal carcinoma via activating MYLK-mediated cGMP-PKG signaling pathway.

Silencing of long noncoding RNA SRRM2-AS exerts suppressive effects on angiogenesis in nasopharyngeal carcinoma via activating MYLK-mediated cGMP-PKG signaling pathway.

Journal: Journal of cellular physiology

Published: April 20, 2019

Activating transcription factor 2 expression mediates cell proliferation and is associated with poor prognosis in human non-small cell lung carcinoma.

Activating transcription factor 2 expression mediates cell proliferation and is associated with poor prognosis in human non-small cell lung carcinoma.

Journal: Oncology letters

Published: October 01, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026